ArticleMolecular cancer2025

Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.

Linjie Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.